Sign up to save your podcasts
Or
Share Treatment Algorithm of Neuroendocrine Tumors (NET) in 2025 - Dr. Thor Halfdanarson
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Treatment Algorithm of Neuroendocrine Tumors (NET) in 2025 - Dr. Thor Halfdanarson
Welcome to the Oncology Brothers podcast! In this episode, we dive deep into the world of neuroendocrine tumors (NETs) with renowned expert Dr. Thor Halfdanarson from the Mayo Clinic.
Join us as we explore:
• The critical factors in diagnosing NETs, including origin, grade, histological features, and Ki-67.
• The importance of differentiating between functional and non-functional tumors and how this impacts treatment decisions.
• Dr. Halfdanarson's treatment paradigm, including the use of somatostatin analogs, radioligand therapy, and other targeted treatments.
• Monitoring strategies for patients, including the role of imaging and tumor markers like 5-HIAA and chromogranin.
• Insights into the evolving role of immunotherapy and next-generation sequencing in managing high-grade neuroendocrine carcinomas.
Whether you're a healthcare professional or simply interested in the latest advancements in oncology, this episode is packed with valuable information and practical insights.
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Don't forget to subscribe for more discussions on cutting-edge cancer treatments and expert opinions in the field of oncology!
View all episodes
By Oncology Brothers
4.8
4040 ratings
Welcome to the Oncology Brothers podcast! In this episode, we dive deep into the world of neuroendocrine tumors (NETs) with renowned expert Dr. Thor Halfdanarson from the Mayo Clinic.
Join us as we explore:
• The critical factors in diagnosing NETs, including origin, grade, histological features, and Ki-67.
• The importance of differentiating between functional and non-functional tumors and how this impacts treatment decisions.
• Dr. Halfdanarson's treatment paradigm, including the use of somatostatin analogs, radioligand therapy, and other targeted treatments.
• Monitoring strategies for patients, including the role of imaging and tumor markers like 5-HIAA and chromogranin.
• Insights into the evolving role of immunotherapy and next-generation sequencing in managing high-grade neuroendocrine carcinomas.
Whether you're a healthcare professional or simply interested in the latest advancements in oncology, this episode is packed with valuable information and practical insights.
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Don't forget to subscribe for more discussions on cutting-edge cancer treatments and expert opinions in the field of oncology!
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
NEJM This Week
324 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Research To Practice | Oncology Videos
120 Listeners
ASCO Daily News
57 Listeners
Mayo Clinic Talks
295 Listeners
White Coat Investor Podcast
2,439 Listeners
The Curbsiders Internal Medicine Podcast
3,358 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
The ONS Podcast
204 Listeners
OncoPharm
187 Listeners
ASCO Guidelines
43 Listeners
OncLive® On Air
22 Listeners
Becker’s Healthcare Podcast
189 Listeners
Oncology Today with Dr Neil Love
59 Listeners
Two Onc Docs
193 Listeners